GlaxoSmithKline Consumer Healthcare (GSKCH) is an associate of GlaxoSmithKline plc UK, which holds 72.46% stake in the company. It is India’s dominant player in health food drink (HFD) category with 67.3% market share. While Horlicks leads the market, Boost is among the top three health food drink brands.
Valuation and view
GSKCH is better placed than peers given its strong pricing power, leadership position and distribution reach in the core HFD portfolio. We expect revenue and PAT to grow at a CAGR of 9.8% and 15.8% over FY15-FY18E. Further, we rate the stock as ‘BUY’ assigning a forward P/E of 31.5x arriving at a target price of Rs. 6,788 which implies potential upside of ~12% for next 12 months.
Research Report GSK Consumer Healthcare Ltd
Investments in equity shares, debentures, etc., are not obligations of, or guaranteed by Wealth India Financial Services Pvt. Ltd., and are subject to investment risks. Click here to read our full disclaimer.
- Merger of Navi Overnight Fund into Navi Liquid Fund and Navi Conservative Hybrid Fund into Navi Aggressive Hybrid Fund
- Intimation of suspension of subscription in Bandhan US Equity Fund of Fund
Winning Funds, Losing Streaks: Decoding the Mystery of Short-Term Underperformance
Wealth Conversations – November 2024- Notice of Change in Fundamental Attributes of DSP Equity & Bond Fund and DSP Quant Fund
